UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 301,070 Shares of Xylem Inc. (NYSE:XYL)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 8.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,750,377 shares of the industrial products company's stock after purchasing an additional 301,070 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 1.54% of Xylem worth $435,119,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. grew its stake in shares of Xylem by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock worth $3,323,325,000 after purchasing an additional 303,854 shares during the period. Geode Capital Management LLC grew its stake in shares of Xylem by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock worth $671,623,000 after purchasing an additional 135,492 shares during the period. Impax Asset Management Group plc grew its stake in shares of Xylem by 231.5% during the fourth quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after purchasing an additional 3,883,845 shares during the period. Royal Bank of Canada lifted its holdings in Xylem by 7.9% during the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after acquiring an additional 320,500 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Xylem by 9.8% in the fourth quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock valued at $465,229,000 after acquiring an additional 359,276 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Down 1.0%

Shares of XYL stock traded down $1.25 on Friday, hitting $124.02. 1,282,303 shares of the stock were exchanged, compared to its average volume of 1,418,319. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $30.18 billion, a P/E ratio of 33.89, a price-to-earnings-growth ratio of 2.33 and a beta of 1.10. The business has a 50-day moving average of $117.57 and a 200 day moving average of $121.52. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.09.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.95 by $0.08. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The firm had revenue of $2.07 billion during the quarter, compared to analysts' expectations of $2.04 billion. During the same period in the prior year, the firm posted $0.90 earnings per share. The business's quarterly revenue was up 1.8% compared to the same quarter last year. Equities analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, May 29th. This represents a $1.60 annualized dividend and a yield of 1.29%. Xylem's dividend payout ratio is 43.01%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on XYL shares. Robert W. Baird decreased their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research note on Wednesday, April 30th. Stifel Nicolaus boosted their target price on Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research note on Wednesday, April 30th. Royal Bank of Canada boosted their target price on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Raymond James raised Xylem to a "hold" rating in a research note on Thursday, May 15th. Finally, Citigroup dropped their price objective on shares of Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $146.88.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.